Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-02 @ 12:50 PM
Study NCT ID:
NCT00398957
Status:
COMPLETED
Last Update Posted:
2010-04-27
First Post:
2006-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
Sponsor:
Alza Corporation, DE, USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR011611
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None